Meta-analysis links longer preparation therapy and follow-up duration to depressive symptom change in psilocybin- and LSD-assisted treatment.
Gianluca Florineth, MSc
Advertisement
Gianluca Florineth, MSc, from the Translational Research Center, University Hospital of Psychiatry and Psychotherapy at the University of Bern in Switzerland.
Articles by Gianluca Florineth, MSc
Greater exposure to preparation therapy before psychedelic dosing was linked to larger reductions in depressive symptoms, a new study found.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Medical Ethics Unpacked: The History and Ethics of Brain Death
2
Pigmentation Pipeline: Vitiligo and Melasma Treatment Advances
3
Saroglitazar and the Evolving PBC Treatment Landscape, With Raj Vuppalanchi, MD
4
Why Fewer Than Half of Referred Patients Reach Kidney Transplant Evaluation
5